Clinical Trials Sponsored by Triphase Research and Development III Corp.

Total 21 results

Triphase Research and Development III Corp.

Completed

Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma

Lymphoma | Lymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, Marginal Zone

Canada, United States
Sanotize Research and Development corp.

Completed

Nitric Oxide Footbath for Treatment of Diabetic Foot Ulcers

Diabetic Foot Ulcer

Canada
Sanotize Research and Development corp.

Active, not recruiting

Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection

SARS-CoV-2 Infection

Canada, Sri Lanka
Sanotize Research and Development corp.

Recruiting

Evaluation of Nitric Oxide Nasal Spray (NONS) for Treatment of Recurrent Acute Rhinosinusitis (NONS-RARS-01)

Recurrent Acute Rhinosinusitis

Canada
Sanotize Research and Development corp.

Completed

Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)

Verruca Plantaris

Canada
Sanotize Research and Development corp.

Recruiting

Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis

Candidiasis, Oral

Canada
Sanotize Research and Development corp.

Completed

Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)

Chronic Sinusitis

Canada
Sanotize Research and Development corp.

Withdrawn

Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection

SARS-CoV Infection
Sanotize Research and Development corp.
Glenmark Pharmaceuticals Ltd. India

Completed

Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19

SARS-CoV-2 Infection

India
Sanotize Research and Development corp.
The Emmes Company, LLC; Keyrus Life Science

Completed

Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection (NOCOVID)

Corona Virus Infection

Canada
Pfizer
Biomedical Advanced Research and Development Authority; Innovative Medicines...

Completed

A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. (REVISIT)

Ventilator Associated Pneumonia | Complicated Intra-abdominal Infection | Hosptial Acquired Pneumonia

Spain, China, Korea, Republic of, Philippines, United States, Romania, Taiwan, Italy, Malaysia, Mexico, India, Israel, Turkey, Greece, Thailand, Czechia, Croatia, Argentina, Russian Federation, Bulgaria, Ukraine
John Paul II Hospital, Krakow
National Center for Research and Development, Poland; KCRI

Completed

Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)

Myocardial Infarction

Poland
John Paul II Hospital, Krakow
National Center for Research and Development, Poland; KCRI

Active, not recruiting

Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)

Critical Limb Ischemia

Poland
John Paul II Hospital, Krakow
National Center for Research and Development, Poland; KCRI

Completed

Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)

Heart Failure

Poland
Hospital General Universitario Gregorio Marañon
Instituto de Salud Carlos III; European Regional Development Fund; Maternal,...

Unknown

Usefulness of Protein-enriched Infant Formula in Pediatric Intensive Care.

Protein-Energy Malnutrition

Spain
International Food Policy Research Institute
United States Agency for International Development (USAID); Food and Nutrition... and other collaborators

Completed

Preventing Malnutrition in Children Under Two Years of Age Approach

Malnutrition

Burundi, Guatemala
Karol Wierzbicki
Medtronic Poland Spółka z ograniczoną odpowiedzialnością; Cor Aegrum Foundation... and other collaborators

Completed

Exercise Tolerance in Patients With Implanted Left Ventricular Assist Device

Left Ventricular Assist Device

Poland
US Department of Veterans Affairs
Bristol-Myers Squibb; Sanofi; GE Healthcare; Merck Sharp & Dohme LLC; Pfizer; Astra... and other collaborators

Completed

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

Myocardial Ischemia

United States, Canada
Vera HM Deneer
Federico II University; University Medical Center Groningen; UMC Utrecht; Onze... and other collaborators

Completed

Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics)

Myocardial Infarction | STEMI

Netherlands, Italy, Belgium
Agricultural University of Athens
General Secretariat of Consumers-Greek Ministry of Development; Hellenic Association... and other collaborators

Completed

Greek Childhood Obesity (GRECO) Study (GRECO)

Obesity | Overweight | Physical Activity | Blood Pressure | Dietary Habits

Greece
Public Health Foundation Enterprises, Inc.
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... and other collaborators

Completed

Comparison of Men's Prevention Apps to Research Efficacy (COMPARE)

Sexually Transmitted Diseases | HIV/AIDS | Risk Reduction | Pre-exposure Prophylaxis

United States

Clinical Trials Sponsored by Triphase Research and Development III Corp.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations